Orthofix Medical Inc (OFIX) - Total Assets
Based on the latest financial reports, Orthofix Medical Inc (OFIX) holds total assets worth $886.60 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Orthofix Medical Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Orthofix Medical Inc - Total Assets Trend (1992–2025)
This chart illustrates how Orthofix Medical Inc's total assets have evolved over time, based on quarterly financial data. See OFIX book value for net asset value and shareholders' equity analysis.
Orthofix Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Orthofix Medical Inc's total assets of $886.60 Million consist of 49.0% current assets and 51.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.6% |
| Accounts Receivable | $135.75 Million | 16.0% |
| Inventory | $34.17 Million | 4.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $72.77 Million | 8.6% |
| Goodwill | $194.93 Million | 22.9% |
Asset Composition Trend (1992–2025)
This chart illustrates how Orthofix Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Orthofix Medical Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Orthofix Medical Inc's current assets represent 49.0% of total assets in 2025, a decrease from 80.6% in 1992.
- Cash Position: Cash and equivalents constituted 9.6% of total assets in 2025, down from 41.6% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 8.0% in 1992.
- Asset Diversification: The largest asset category is goodwill at 22.9% of total assets.
Orthofix Medical Inc Competitors by Total Assets
Key competitors of Orthofix Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Orthofix Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.87 | 2.71 | 3.17 |
| Quick Ratio | 1.76 | 1.50 | 2.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $300.49 Million | $246.19 Million | $176.81 Million |
Orthofix Medical Inc - Advanced Valuation Insights
This section examines the relationship between Orthofix Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.92 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | -4.8% |
| Total Assets | $850.65 Million |
| Market Capitalization | $398.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values Orthofix Medical Inc's assets below their book value (0.47x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Orthofix Medical Inc's assets decreased by 4.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Orthofix Medical Inc (1992–2025)
The table below shows the annual total assets of Orthofix Medical Inc from 1992 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $850.65 Million | -4.77% |
| 2024-12-31 | $893.29 Million | -3.46% |
| 2023-12-31 | $925.32 Million | +101.76% |
| 2022-12-31 | $458.63 Million | -3.78% |
| 2021-12-31 | $476.62 Million | -9.36% |
| 2020-12-31 | $525.86 Million | +6.10% |
| 2019-12-31 | $495.62 Million | +6.21% |
| 2018-12-31 | $466.64 Million | +15.12% |
| 2017-12-31 | $405.35 Million | +8.94% |
| 2016-12-31 | $372.10 Million | -7.03% |
| 2015-12-31 | $400.22 Million | +1.79% |
| 2014-12-31 | $393.19 Million | -7.94% |
| 2013-12-31 | $427.10 Million | -15.30% |
| 2012-12-31 | $504.28 Million | -27.50% |
| 2011-12-31 | $695.55 Million | +15.16% |
| 2010-12-31 | $603.99 Million | +2.29% |
| 2009-12-31 | $590.47 Million | +5.21% |
| 2008-12-31 | $561.22 Million | -36.63% |
| 2007-12-31 | $885.66 Million | +2.71% |
| 2006-12-31 | $862.28 Million | +81.97% |
| 2005-12-31 | $473.86 Million | +9.92% |
| 2004-12-31 | $431.10 Million | +4.34% |
| 2003-12-31 | $413.18 Million | +87.15% |
| 2002-12-31 | $220.77 Million | +16.86% |
| 2001-12-31 | $188.91 Million | -0.80% |
| 2000-12-31 | $190.43 Million | +39.29% |
| 1999-12-31 | $136.72 Million | +11.70% |
| 1998-12-31 | $122.40 Million | +8.41% |
| 1997-12-31 | $112.90 Million | -0.18% |
| 1996-12-31 | $113.10 Million | +8.75% |
| 1995-12-31 | $104.00 Million | +83.42% |
| 1994-12-31 | $56.70 Million | +17.88% |
| 1993-12-31 | $48.10 Million | +31.78% |
| 1992-12-31 | $36.50 Million | -- |
About Orthofix Medical Inc
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more